Risk factors for thromboembolism: pathophysiology and detection

Solymoss, Susan
October 2000
CMAJ: Canadian Medical Association Journal;10/17/2000, Vol. 163 Issue 8, p991
Academic Journal
Focuses on hypercoagulability and its association with a risk of venous thromboembolism. Overview of procoagulant and anticoagulant reactions which promote a hypercoagulable state; Importance of the hemostatic balance; Application of the study for treatment of patients.


Related Articles

  • A Guide to Disorders of Hemostasis. Goulian, Mehran // Annals of Internal Medicine;Oct66, Vol. 65 Issue 4, p782 

    Presents a guide for the diagnosis and treatment of hemostasis disorders. Areas of hemostatic mechanisms; Hypothetical scheme for mechanism of blood coagulation; Classification of hemostasis disorders.

  • Recombinant Activated Factor VII: Current Perspectives and Epworth Experience Labattaglia, Matthew P.; Ihle, Benno // Heart, Lung & Circulation;Jun2007 Supplement 3, Vol. 16 Issue s3, pS96 

    Recombinant factor VII was first developed for control and prevention of bleeding in haemophilia with antibodies to factor VIII and IX. Its efficacy in these situations is well established. Over recent years, the ‘off-label’ use of this substance has become more widespread in...

  • Q / Does hypercoagulopathy testing benefit patients with DVT? Saultz, Alisha; Mathews, Erin Lindsay; Saultz, John W.; Dolores Judkins // Journal of Family Practice;May2010, Vol. 59 Issue 5, p291 

    The article discusses vital answer regarding the benefits of hypercoagulopathy testing or thrombophilia test on deep venuos thrombosis (DVT) patients. It focuses on the testing on patients with recurrent episodes of thromboembolism or idiopathic DVT in risk assessment to other family members. It...

  • Thrombophiliescreening 2011: Wer soll wann untersucht werden? Graf, L.; Tsakiris, D. A. // Praxis (16618157);4/4/2012, Vol. 101 Issue 7, p465 

    Heritable thrombophilia as a concept in hemostasis has been continuously discovered parallel to the knowledge on physiology of bleeding disorders. Since the 1980s it has become increasingly popular to search for thrombophilia in patients with thromboembolism and their relatives. Although...

  • KaraciÄŸer hastalıklarında pıhtılaÅŸma-tromboz mekanizmasına neler oluyor? Tiraje Celkan, Tülin // Turkish Pediatrics Archive / Turk Pediatri Arsivi;Jun2013, Vol. 48 Issue 2, p94 

    Children with liver disease present complex and varied acquired coagulation abnormalities. Liver is the place where clotting factors are produced as well as inhibitors of coagulation and fibrinolytic system components. Although 75-85% of patients with liver disease show abnormal laboratory...

  • How to use... lupus anticoagulants. Sen, Ethan S.; Beresford, Michael W.; Avčin, Tadej; Ramanan, A. V. // Archives of Disease in Childhood -- Education & Practice Edition;Apr2013, Vol. 98 Issue 2, p52 

    The article highlights which children should be tested for lupus anticoagulants (LA), and the significance of LA if they are detected. It provides an overview of the pathophysiological mechanisms of LA causing thrombosis in vivo. It notes the guidelines for the diagnosis of LA produced by the...

  • Numerical simulation of the coagulation dynamics of blood. Bodnár, T.; Sequeira, A. // Computational & Mathematical Methods in Medicine;Jun2008, Vol. 9 Issue 2, p83 

    The process of platelet activation and blood coagulation is quite complex and not yet completely understood. Recently, a phenomenological meaningful model of blood coagulation and clot formation in flowing blood that extends existing models to integrate biochemical, physiological and rheological...

  • Primena trombinskog praha posle ekstrakcije zuba kod bolesnika koji primaju antikoagulantnu terapiju. Marjanovic, Marjan // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul/Aug2002, Vol. 59 Issue 4, p389 

    Patients with extreme hypocoagulation, which occurs either as an effect of some diseases with coagulation deficiency or because of the anticoagulant therapy (ACT), are a risk group for oral surgery. In the last decades decision to change or interrupt ACT before and after the procedure was...

  • Therapieoptionen der perioperativ erworbenen Thrombozytopathie. Weber, C. F.; Schneider, A. C.; Kirschning, T.; Hofstetter, C.; Zacharowski, K.; Görlinger, K. // Anaesthesist;Sep2009, Vol. 58 Issue 9, p931 

    Increased intra-operative and postoperative blood loss might be caused by acquired platelet function disorders. In particular because conventional coagulation analyses and platelet count fail to detect impaired platelet function, implementation of bedside-tests for platelet function in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics